WebMD

ERS Genomics Appoints John E Milad as Chief Executive Officer

Retrieved on: 
Lunedì, Maggio 13, 2024
Science, Biotechnology, Research, Pharmaceutical, Health, Medical Devices, Health Technology, Genetics, Quanta, ACT, Yeast, Patient, Cas9, Atlas Venture, Synthetic biology, Gene editing, Emmanuelle, Patent, Royal Academy of Arts, CFO, Investment, University, NIHR, Bacteria, Nobel Prize, Royal, Partner, Archaea, WebMD, ERS, Cell, Genomics, CRISPR, Atlas, Prokaryote, Agriculture, Entrepreneurship, Pharmaceutical industry

ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect.

Key Points: 
  • ERS Genomics Limited (‘ERS’), the CRISPR licensing company, today announced the appointment of John E Milad as CEO, with immediate effect.
  • John brings over 25 years of experience as an executive leader, venture capitalist, and investment banker focused on the life sciences and medical technology sectors.
  • Shaun Foy, Co-Founder and Chair of the Board of Directors, ERS Genomics, commented: “On behalf of the Board and executive team, I would like to welcome John as CEO.
  • ERS Genomics licenses these patents via its direct license from Emmanuelle Charpentier and now has nearly 150 licenses in place worldwide.

IPG Health Unlocks Next-Gen Data, AI & Tech-Enabled Platforms for Healthcare

Retrieved on: 
Lunedì, Maggio 6, 2024
HCP, Investment, Acxiom, IPG, AI, Health, WebMD, Activation, SOLVE, Intelligence, Noise, Creativity, EPIC, Video game

“The imperative for health and pharma marketers remains clear – harness this transformative potential to reshape HCP and consumer engagement, drive behavioral change, while accelerating brand value, *with* speed and scale,” said Dana Maiman, CEO of IPG Health.

Key Points: 
  • “The imperative for health and pharma marketers remains clear – harness this transformative potential to reshape HCP and consumer engagement, drive behavioral change, while accelerating brand value, *with* speed and scale,” said Dana Maiman, CEO of IPG Health.
  • “Interconnectivity and interoperability have been fundamental to the success of IPG Health and enable us to keep pace with tech evolution.
  • Integrating this best-in-class data stack with AI resulted in the creation of EPIC – IPG Health’s revolutionary data and insights platform that is purpose-built for healthcare.
  • “This provides scalable and adaptable modular content, optimizing the efficiency of the omnichannel experience,” said Jessica Specker, Executive Director of Global Content Solutions at IPG Health.

Chris Hackney joins Meltwater as Chief Product Officer

Retrieved on: 
Giovedì, Aprile 18, 2024
Learning, Mercury, Responsibility, Heart, WebMD, Software as a service, Oracle, Growth, Meltwater, CRM, Organization, SAN

SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- Meltwater , a leading global provider of social, media and consumer intelligence, today announces the appointment of Chris Hackney as Chief Product Officer.

Key Points: 
  • SAN FRANCISCO, April 18, 2024 (GLOBE NEWSWIRE) -- Meltwater , a leading global provider of social, media and consumer intelligence, today announces the appointment of Chris Hackney as Chief Product Officer.
  • Hackney joins Meltwater with over 25 years in technology and a proven track record of driving innovation and growth for B2B SaaS companies, developing and executing product strategies and managing cross-functional teams.
  • At Meltwater, Hackney will lead the execution of a product vision that is in harmony with Meltwater's core business objectives including industry-leading innovation and a customer-centric approach to product design.
  • “We’re thrilled to bring Chris on board to lead product development and create even more value for our customers.

Forian Inc. Announces the Passing of Director Martin J. Wygod

Retrieved on: 
Domenica, Aprile 14, 2024
WebMD, Internet Brands, Love, Horse, Del Mar Fairgrounds, Medco, Data science, Merck & Co., Physician, KKR, Drug utilization review, Organic, Pharmaceutical industry

He is the father of Forian Executive Chairman, Chief Executive Officer and President, Max Wygod.

Key Points: 
  • He is the father of Forian Executive Chairman, Chief Executive Officer and President, Max Wygod.
  • Marty was at the forefront of the revolution in medical and healthcare information.
  • His companies improved medical decisions and lowered healthcare costs in the United States for millions while generating value for his shareholders.
  • Prior to his contributions to Forian, Marty was the Chairman and Chief Executive Officer of WebMD Health Corp.

Significant Negative Economic and Personal Impact of "Life Change Events" on Employees and Employers Alike, ApiaryLife Survey Finds

Retrieved on: 
Giovedì, Aprile 11, 2024
Professional Services, Business, Other Professional Services, Insurance, Human Resources, Finance, Personal Finance, University, Cancer, Grief, Health, WebMD, Workplace, Research, Appetite, Miscarriage, Dementia, Life, Divorce, Literature, Mental health, Presenteeism, Headache, Fatigue, Caregiver, Child, Absenteeism, Person, Prevalence

The survey also identifies high negative impact on caretakers of affected individuals.

Key Points: 
  • The survey also identifies high negative impact on caretakers of affected individuals.
  • Based on responses from over 500 employees, the survey then confirms these economic and emotional effects via a review of extensive literature on the same topics.
  • Katie also spoke of a few occasions where ApiaryLife experts have saved employee users hundreds of thousands of dollars in corrected mistakes in paperwork!
  • Employer Impact: The high costs to employers of such less-productive work scenarios is obvious with other illnesses, such as cancer.

WebMD Ignite Unveils HealthHub Interactive to Support Health Plans' Clinical Programs

Retrieved on: 
Giovedì, Aprile 25, 2024
Education, Social media, AI, EVP, Health, WebMD, HEDIS, Acquisition, Marketing, Organization, Nursing

NEWARK, N.J., April 25, 2024 /PRNewswire/ -- WebMD Ignite, a full-service growth partner for organizations across the healthcare industry, today announced HealthHub Interactive for health plans, a suite of new technology-driven solutions specifically designed to power health plan clinical programs.

Key Points: 
  • HealthHub Interactive combines WebMD Ignite's industry-leading HealthHub, HealthAdvisor and HealthInteractive services tailored for health plans' population-health and outreach efforts
    NEWARK, N.J., April 25, 2024 /PRNewswire/ -- WebMD Ignite , a full-service growth partner for organizations across the healthcare industry, today announced HealthHub Interactive for health plans, a suite of new technology-driven solutions specifically designed to power health plan clinical programs.
  • HealthHub Interactive bundles three proven WebMD Ignite applications together, including HealthHub, HealthAdvisor, and HealthInteractive, which have been adapted specifically for health plan use cases.
  • For health plan clinical teams responsible for care-management programs, HealthHub Interactive also is perfect for enrolling and engaging specific member populations, using WebMD Ignite's industry-leading educational and interactive content and other resources.
  • HealthHub Interactive also complements other WebMD Ignite solutions that help with engaging additional key audiences, like healthcare professionals within their networks.

Anixa Biosciences Welcomes Celebrity Oncologist Dr. Sanjay Juneja to its Cancer Business Advisory Board

Retrieved on: 
Giovedì, Aprile 18, 2024
Doctor of Philosophy, Personality, Cancer, Sanjay, Health equity, PBS, Hope, Capital region, Entrepreneur (magazine), WebMD, American Cancer Society, MD, The Washington Post, Vaccine, Medicine, Therapy, Patient, CNBC, Social media, Samma (tribe), Knowledge, Pharmaceutical industry

SAN JOSE, Calif., April 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Sanjay Juneja, MD to its Cancer Business Advisory Board.

Key Points: 
  • SAN JOSE, Calif., April 18, 2024 /PRNewswire/ -- Anixa Biosciences, Inc. ("Anixa" or the "Company") (NASDAQ: ANIX), a clinical-stage biotechnology company focused on the treatment and prevention of cancer, today announced the appointment of Sanjay Juneja, MD to its Cancer Business Advisory Board.
  • Anixa Chairman and CEO Dr. Amit Kumar stated, "Dr. Juneja is an accomplished medical oncologist who has earned status as a top media personality on cancer prevention and treatment innovations.
  • Dr. Sanjay Juneja is a board-certified hematologist and medical oncologist currently practicing in Baton Rouge, Louisiana.
  • Anixa Biosciences' Cancer Business Advisory Board is an elite group that includes members such as Karen Knudsen, Ph.D., current CEO of the American Cancer Society; Gary Reedy, previous CEO of the American Cancer Society; Mike Shepard, Ph.D., inventor of Herceptin; and many others.

Renowned NYC Foot Surgeon Dr. Stuart J. Mogul Introduces the Revolutionary Lapiplasty Mini-Incision™ Procedure for Accelerated Healing and Recovery

Retrieved on: 
Martedì, Aprile 9, 2024
ABC, Self (magazine), The New York Times, Weight-bearing, Patient, WebMD, Treace Medical Concepts, News, American College, Publication, Fox News, Position, Multimedia, ABC News, Dentistry

NEW YORK, April 9, 2024 /PRNewswire-PRWeb/ -- Dr. Stuart J. Mogul, a distinguished foot surgeon based in New York City, is proud to announce the incorporation of the groundbreaking Lapiplasty Mini-Incision™ Procedure into his practice. Developed by Treace Medical Concepts, this innovative surgical technique offers patients faster healing, quicker recovery times, and the ability to bear weight sooner following foot procedures.

Key Points: 
  • Patients requiring foot surgery have long relied on the expertise of esteemed New York Foot Surgeon, Dr. Stuart J.
  • Mogul, a distinguished foot surgeon based in New York City , is proud to announce the incorporation of the groundbreaking Lapiplasty Mini-Incision™ Procedure into his practice.
  • The Lapiplasty Mini-Incision™ Procedure revolutionizes foot surgery by addressing issues related to metatarsal alignment through a streamlined and highly effective approach.
  • Dr. Stuart Mogul is a diplomate of The American Board of Foot & Ankle Surgery and fellow of the American College of Foot and Ankle Surgeons.

Lovell Minnick Partners Appoints Marshall Lux and Robert Orefice to Advisory Council

Retrieved on: 
Giovedì, Marzo 14, 2024
Professional Services, Finance, BCG, Aetion, Risk management, Growth, Private equity, Flagstar, Princeton University, Advisory Council, Risk, Health, Financial services, Harvard Business School, WebMD, Computer engineering, Walden University, LMP, Lovell Minnick Partners, AMD, Investment, Partnership, McKinsey & Company, Rochester Institute of Technology, Computer, Economics, Chase

Lovell Minnick Partners (“LMP”), a private equity firm investing in growth-oriented companies, today announced the appointment of Marshall Lux and Robert Orefice to its Advisory Council.

Key Points: 
  • Lovell Minnick Partners (“LMP”), a private equity firm investing in growth-oriented companies, today announced the appointment of Marshall Lux and Robert Orefice to its Advisory Council.
  • Marshall Lux brings over 35 years of experience and most recently served as Senior Partner at BCG and McKinsey, where he focused on all manner of Financial Services and Private Equity.
  • Marshall also serves as an independent member of various Boards, including Mphasis, Flagstar and Guardian Life Mutual Funds.
  • "We are excited to welcome Marshall and Robert as the newest members of our Advisory Council,” says Steve Pierson, Managing Partner at LMP.

rater8 Accelerates Expansion With Strategic Investment

Retrieved on: 
Giovedì, Aprile 4, 2024
Partner, Software as a service, Growth, Vital, Practice management, Health, Adviser, Patient, Hospital, WebMD, Patient satisfaction, EHR, Healthgrades, Nursing

MONTVALE, N.J., April 4, 2024 /PRNewswire/ -- rater8, a leader in healthcare reputation management and patient feedback solutions, today announced the close of a Series A funding round led by Elsewhere Partners. rater8 will use the growth financing to further expand its market reach to medical practices and hospitals of all types and sizes, while continuing to build out its team, deepen industry partnerships and enhance its award-winning SaaS solutions to meet the changing needs of patients and the modern healthcare community.

Key Points: 
  • "rater8 plays a pivotal role in our mission to drive healthcare organizational growth and excellence.
  • "As the healthcare sector evolves, healthtech innovators are clamoring to carve out their niche in an increasingly crowded space.
  • We see tremendous opportunity for growth as rater8 further broadens the capabilities of its platform and grows its team to support demand.
  • Michele Perry will take on the role of executive chairman alongside Robbie Abt and Joel Dolisy, who will join as advisors.